Identifies Klebsiella phage PMBT63's therapeutic potential and interactions with mucin, suggesting new applications.
Three novel Klebsiella phages, PMBT12, PMBT63, and PMBT64, were isolated and characterized. The phages revealed distinct morphologies, phylogenetic backgrounds, and a high degree of genomic divergence. PMBT12 and PMBT64 exhibited narrow host ranges, whereas PMBT63 demonstrated a broader host range across the tested Klebsiella strains with diverse sequence and capsule types. PMBT63 possesses a large genome that approaches the size of jumbo T4-like phages, encodes 16 tRNAs, and exhibits high thermal stability up to 70°C. A conserved Hoc-like protein in PMBT63 was identified and structurally characterized, showing a highly conserved genomic context across diverse Enterobacteriaceae phages. Computational analyses predicted putative mucin-binding sites within this protein, which was corroborated experimentally by enhanced phage retention on mucin-coated surfaces. IMPORTANCE These findings identify Klebsiella phage PMBT63 as a promising candidate for therapeutic applications. It also highlights the importance of characterizing phages for potential phage-mucin interactions, which may influence their persistence and function within the gastrointestinal tract.
No takes yet. Share an insight, caveat, or question.
Ewertz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: